SCHEMBL30120729

SCHEMBL30120729

COc1cccc(-n2ncc3c(O)nc(CCl)nc32)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.50
TSHR P16473 3/20 0.50
HTT P42858 2/20 0.50
LMNA P02545 2/20 0.49
POLB P06746 4/20 0.48
ALDH1A1 P00352 3/20 0.48
MAPT P10636 2/20 0.48
HPGD P15428 2/20 0.48
CYP17A1 P05093 1/20 0.44
CYP1A2 P05177 1/20 0.44
TP53 P04637 3/20 0.43
GSK3B P49841 3/20 0.43
KDM4E B2RXH2 2/20 0.43
USP7 Q93009 1/20 0.43
GAA P10253 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
MEN1 O00255 1/20 0.42
XBP1 P17861 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23723574 1.00 SMN1; SMN2 (0.50) SMN1; SMN2TSHRHTTLMNAPOLB
SCHEMBL26525969 0.87 ALDH1A1 (0.48) SMN1; SMN2TSHRHTTLMNAPOLB
SCHEMBL23723775 0.87 SMN1; SMN2 (0.51) SMN1; SMN2TSHRHTTLMNAPOLB
SCHEMBL23723551 0.86 GRM1 (0.52) SMN1; SMN2TSHRHTTLMNAALDH1A1
SCHEMBL30120767 0.86 GRM1 (0.52) SMN1; SMN2TSHRHTTLMNAALDH1A1
SCHEMBL1353714 0.83 TSHR (0.53) SMN1; SMN2TSHRHTTLMNAPOLB
SCHEMBL23723660 0.82 KMT2A (0.47) SMN1; SMN2TSHRLMNAPOLBALDH1A1
SCHEMBL1356011 0.80 TSHR (0.50) SMN1; SMN2TSHRHTTLMNAPOLB
SCHEMBL23723527 0.78 SMN1; SMN2 (0.51) SMN1; SMN2TSHRHTTLMNAMAPT
SCHEMBL23723600 0.78 SLC2A1 (0.45) LMNAALDH1A1MAPTCYP17A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4100015-A1 COMBINATION THERAPY FOR TREATING MPS1 Gain Therapeutics SA (CH) 2022-12-14 EP disclosed
CN-115397423-A Combination therapy for the treatment of MPS1 增益治疗股份有限公司 2022-11-25 CN disclosed